D.E. Shaw & Co
GNOM icon

D.E. Shaw & Co’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

D.E. Shaw & Co’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,665
Closed -$142K – 4434
2024
Q4 		$142K Sell
3,665
-2,861
-44% -$120K ﹤0.01% 4135
2024
Q3 		$294K Buy
6,526
+1,464
+29% +$65.4K ﹤0.01% 3985
2024
Q2 		$211K Buy
+5,062
New +$212K ﹤0.01% 4054

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

D.E. Shaw & Co's GNOM Position: Q1 2025 in Review

D.E. Shaw & Co sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 3,665 shares — an estimated $142K sold.

D.E. Shaw & Co first reported a position in GNOM in Q2 2024 and held it in 3 quarters. The position peaked at $294K in Q3 2024. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

  • D.E. Shaw & Co reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,665 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $142K.
  • D.E. Shaw & Co first reported a position in Global X Genomics & Biotechnology ETF in Q2 2024 and held it in 3 quarters.
  • D.E. Shaw & Co's Global X Genomics & Biotechnology ETF position peaked at $294K in Q3 2024.
  • 60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.